The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Checked against the public recordLast updated Mar 5, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- UMC Utrecht
- Interventions being studied
- Radiation: Radiation therapy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac; * Patient provides written, informed consent; * Patient is 18 years old or older. Exclusion Criteria: * MRI exclusion criteria, including * MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Allegheny Health NetworkPittsburgh, Pennsylvania
- Md Anderson Cancer CenterHouston, Texas
- Medical College of WisconsinMilwaukee, Wisconsin
- Austin Health - Olivia Newton-John Cancer Wellness and Research CentreMelbourne
- Insitut Jules BordetBrussels
- Sunnybrook Health Sciences Centre/Odette Cancer CentreToronto, Ontario
- University Health Network - Princess Margaret Cancer CenterToronto
- Odense UniversitetshospitalOdense, Funen
- Universitätsklinikum TübingenTübingen
- Università degli Studi di BresciaBrescia
- IRCCS Ospedale Sacro Cuore Don CalabriaNegrar
- Netherlands Cancer Institute, Antoni van Leeuwenhoek HospitalAmsterdam
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 5, 2026. Always confirm current availability with the study team.